14-3-3β exerts glioma-promoting effects and is associated with malignant progression and poor prognosis in patients with glioma.

Liu L, Liu Z, Wang H, Chen L, Ruan F, Zhang J, Hu Y, Luo H, Wen S

Open source

DOI
10.3892/etm.2017.5664
Published
2018 Mar
Container
Experimental and therapeutic medicine
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3892/etm.2017.5664,
  title = {14-3-3β exerts glioma-promoting effects and is associated with malignant progression and poor prognosis in patients with glioma.},
  author = {Liu L and Liu Z and Wang H and Chen L and Ruan F and Zhang J and Hu Y and Luo H and Wen S},
  year = {2018},
  journal = {Experimental and therapeutic medicine},
  doi = {10.3892/etm.2017.5664},
  url = {https://doi.org/10.3892/etm.2017.5664}
}

RIS

TY  - JOUR
TI  - 14-3-3β exerts glioma-promoting effects and is associated with malignant progression and poor prognosis in patients with glioma.
AU  - Liu L
AU  - Liu Z
AU  - Wang H
AU  - Chen L
AU  - Ruan F
AU  - Zhang J
AU  - Hu Y
AU  - Luo H
AU  - Wen S
PY  - 2018
JO  - Experimental and therapeutic medicine
DO  - 10.3892/etm.2017.5664
UR  - https://doi.org/10.3892/etm.2017.5664
ER  - 

APA

L, L., Z, L., H, W., L, C., F, R., J, Z., Y, H., H, L., & S, W. (2018). 14-3-3β exerts glioma-promoting effects and is associated with malignant progression and poor prognosis in patients with glioma.. Experimental and therapeutic medicine. https://doi.org/10.3892/etm.2017.5664

Source records